BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33741492)

  • 1. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
    Shao K; Zhou Z; Xun P; Cohen SM
    Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
    Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
    Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
    Saint-Jacques N; Parker L; Brown P; Dummer TJ
    Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach.
    Tsuji JS; Chang ET; Gentry PR; Clewell HJ; Boffetta P; Cohen SM
    Crit Rev Toxicol; 2019 Jan; 49(1):36-84. PubMed ID: 30932726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Inorganic Arsenic Exposure from U.S. Rice and Total Water Intakes.
    Mantha M; Yeary E; Trent J; Creed PA; Kubachka K; Hanley T; Shockey N; Heitkemper D; Caruso J; Xue J; Rice G; Wymer L; Creed JT
    Environ Health Perspect; 2017 May; 125(5):057005. PubMed ID: 28572075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review and Meta-Regression Analysis of Lung Cancer Risk and Inorganic Arsenic in Drinking Water.
    Lamm SH; Ferdosi H; Dissen EK; Li J; Ahn J
    Int J Environ Res Public Health; 2015 Dec; 12(12):15498-515. PubMed ID: 26690190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
    Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
    Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumption of low-moderate level arsenic contaminated water does not increase spontaneous pregnancy loss: a case control study.
    Bloom MS; Neamtiu IA; Surdu S; Pop C; Lupsa IR; Anastasiu D; Fitzgerald EF; Gurzau ES
    Environ Health; 2014 Oct; 13():81. PubMed ID: 25311704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benchmark Dose Modeling Estimates of the Concentrations of Inorganic Arsenic That Induce Changes to the Neonatal Transcriptome, Proteome, and Epigenome in a Pregnancy Cohort.
    Rager JE; Auerbach SS; Chappell GA; Martin E; Thompson CM; Fry RC
    Chem Res Toxicol; 2017 Oct; 30(10):1911-1920. PubMed ID: 28927277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of dietary inorganic arsenic to serum matrix metalloproteinase-9 (MMP-9) at different threshold concentrations of tap water arsenic.
    Kurzius-Spencer M; Harris RB; Hartz V; Roberge J; Hsu CH; O'Rourke MK; Burgess JL
    J Expo Sci Environ Epidemiol; 2016 Sep; 26(5):445-51. PubMed ID: 25605447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic in drinking water and lung cancer: A systematic review of 35 years of evidence.
    Issanov A; Adewusi B; Saint-Jacques N; Dummer TJB
    Toxicol Appl Pharmacol; 2024 Feb; 483():116808. PubMed ID: 38218206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between lifetime exposure to inorganic arsenic in drinking water and coronary heart disease in Colorado residents.
    James KA; Byers T; Hokanson JE; Meliker JR; Zerbe GO; Marshall JA
    Environ Health Perspect; 2015 Feb; 123(2):128-34. PubMed ID: 25350952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic.
    Gibb H; Haver C; Gaylor D; Ramasamy S; Lee JS; Lobdell D; Wade T; Chen C; White P; Sams R
    Environ Health Perspect; 2011 Mar; 119(3):284-90. PubMed ID: 21030336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.
    Gentry PR; Yager JW; Clewell RA; Clewell HJ
    Toxicol In Vitro; 2014 Oct; 28(7):1196-205. PubMed ID: 24937311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
    Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
    J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
    Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the carcinogenicity of inorganic arsenic.
    Cohen SM; Arnold LL; Beck BD; Lewis AS; Eldan M
    Crit Rev Toxicol; 2013 Oct; 43(9):711-52. PubMed ID: 24040994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential concepts for interpreting the dose-response of low-level arsenic exposure in epidemiological studies.
    Tsuji JS; Lennox KP; Watson HN; Chang ET
    Toxicology; 2021 Jun; 457():152801. PubMed ID: 33905760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.